Drug Patents owned by Vifor Fresenius

1. Drug name - VELPHORO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10695367 VIFOR FRESENIUS Pharmaceutical compositions Nov, 2028

(6 years from now)

US11013762 VIFOR FRESENIUS Pharmaceutical compositions Nov, 2028

(6 years from now)

US10933090 VIFOR FRESENIUS Pharmaceutical compositions Nov, 2028

(6 years from now)

US10925896 VIFOR FRESENIUS Pharmaceutical compositions Nov, 2028

(6 years from now)

US10682376 VIFOR FRESENIUS Pharmaceutical compositions Nov, 2028

(6 years from now)

US10925897 VIFOR FRESENIUS Pharmaceutical compositions Nov, 2028

(6 years from now)

US11013761 VIFOR FRESENIUS Pharmaceutical compositions Nov, 2028

(6 years from now)

US10695367

(Pediatric)

VIFOR FRESENIUS Pharmaceutical compositions May, 2029

(6 years from now)

US10925896

(Pediatric)

VIFOR FRESENIUS Pharmaceutical compositions May, 2029

(6 years from now)

US10925897

(Pediatric)

VIFOR FRESENIUS Pharmaceutical compositions May, 2029

(6 years from now)

US10933090

(Pediatric)

VIFOR FRESENIUS Pharmaceutical compositions May, 2029

(6 years from now)

US10682376

(Pediatric)

VIFOR FRESENIUS Pharmaceutical compositions May, 2029

(6 years from now)

US11013761

(Pediatric)

VIFOR FRESENIUS Pharmaceutical compositions May, 2029

(6 years from now)

US11013762

(Pediatric)

VIFOR FRESENIUS Pharmaceutical compositions May, 2029

(6 years from now)

US9561251 VIFOR FRESENIUS Pharmaceutical compositions Jan, 2030

(7 years from now)

US9561251

(Pediatric)

VIFOR FRESENIUS Pharmaceutical compositions Jul, 2030

(7 years from now)

US11234938 VIFOR FRESENIUS Pharmaceutical composition, comprising phosphate binder particles Nov, 2034

(12 years from now)

US10624855 VIFOR FRESENIUS Pharmaceutical composition, comprising phosphate binder particles Nov, 2034

(12 years from now)

US10624855

(Pediatric)

VIFOR FRESENIUS Pharmaceutical composition, comprising phosphate binder particles May, 2035

(12 years from now)

Drugs and Companies using FERRIC OXYHYDROXIDE ingredient

Treatment: Control of phosphorous levels in patients

Dosage: TABLET, CHEWABLE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 500MG IRON TABLET, CHEWABLE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.